Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal CancerTerminated
NCT01849874Phase 3Updated Oct 30, 2023
Sponsor: Pfizer
Low-grade Serous Ovarian Cancer · Low-grade Serous Fallopian Tube Cancer · Low-grade Serous Peritoneal Cancer
United States, Australia, Austria, Belgium, Canada +14 more
A Study of ARRY-502 in Patients With Persistent AsthmaCompleted
NCT01561690Phase 2Updated Oct 30, 2023
Sponsor: Pfizer
Asthma
United States
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisCompleted
NCT03334851Phase 1Updated Oct 30, 2023
Sponsor: Pfizer
Systemic Lupus Erythematosus · Rheumatoid Arthritis
United States
Antibiotic Treatment of Gulf War Veterans' IllnessesCompleted
NCT00007735Phase 3Updated Oct 30, 2023
Sponsor: US Department of Veterans Affairs
Persian Gulf Syndrome · Mycoplasma Infections
United States, Puerto Rico
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund DatabaseCompleted
NCT05286528N/AUpdated Oct 27, 2023
Sponsor: Pfizer
Chronic Myeloid Leukaemia
Hungary
Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of AgeCompleted
NCT05301322Phase 3Updated Oct 27, 2023
Sponsor: Pfizer
Respiratory Syncytial Virus
Australia
Circadian Rhythms of Aqueous Humor Dynamics in HumansCompleted
NCT00572936Phase 2Updated Oct 24, 2023
Sponsor: University of Nebraska
Glaucoma
United States
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.Completed
NCT02840721Phase 2Updated Oct 23, 2023
Sponsor: Telavant, Inc.
Colitis, Ulcerative
United States, Belgium, Italy, Netherlands, Poland +1 more
Pregabalin for Abdominal Pain From AdhesionsTerminated
NCT00310765Phase 4Updated Oct 23, 2023
Sponsor: Henry Ford Health System
Abdominal Pain · Surgical Adhesions
United States
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant MesotheliomaCompleted
NCT03399552Phase 1, Phase 2Updated Oct 23, 2023
Sponsor: Memorial Sloan Kettering Cancer Center
Malignant Mesothelioma (MPM)
United States
Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's DiseaseWithdrawn
NCT05471492Phase 2Updated Oct 19, 2023
Sponsor: Telavant, Inc.
Crohn Disease
Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy ParticipantsCompleted
NCT04269538Phase 1Updated Oct 19, 2023
Sponsor: Telavant, Inc.
Healthy
Japan
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.Completed
NCT01989143Phase 1Updated Oct 19, 2023
Sponsor: Telavant, Inc.
Healthy
United States
Risk Factors for Advanced Fibrosis Among FLD PatientsUnknown
NCT05971082N/AUpdated Oct 17, 2023
Sponsor: Helsinki University Central Hospital
NAFLD · Liver Cirrhosis · Diabetes Mellitus, Type 2
Finland
Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)Completed
NCT04706793Phase 3Updated Oct 16, 2023
Sponsor: Pfizer
Ulcerative Colitis
Japan
Wearable Skin Sensors to Assess Nocturnal Scratch BehaviorCompleted
NCT03770858N/AUpdated Oct 13, 2023
Sponsor: Northwestern University
Atopic Dermatitis
United States
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsTerminated
NCT03330405Phase 1, Phase 2Updated Oct 13, 2023
Sponsor: Pfizer
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
United States, Australia, Belgium, Canada, Denmark +4 more
BrUOG 390: Neoadjuvant Treatment With TalazoparibTerminated
NCT04598321Phase 1Updated Oct 12, 2023
Sponsor: Brown University
BRCA1 Mutation · BRCA2 Mutation · Ovarian Cancer · Fallopian Tube Cancer
United States
Fetal Hemoglobin Induction Treatment MetforminCompleted
NCT02981329EARLY_Phase 1Updated Oct 12, 2023
Sponsor: Baylor College of Medicine
Sickle Cell Anemia · Sickle Cell Disease · Hemoglobin Disorder
United States
Pneumonia Research and Vaccine Impact LeagueCompleted
NCT03900520N/AUpdated Oct 11, 2023
Sponsor: Johns Hopkins Bloomberg School of Public Health
Pneumonia
India
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With RitonavirCompleted
NCT04962230Phase 1Updated Oct 10, 2023
Sponsor: Pfizer
Healthy Participant
United States
STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORSCompleted
NCT04635631Phase 1Updated Oct 10, 2023
Sponsor: Pfizer
Neoplasms
China
Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsCompleted
NCT02897375Phase 1Updated Oct 10, 2023
Sponsor: Emory University
Solid Neoplasm · Stage III Pancreatic Cancer · Stage IIIA Breast Cancer · Stage IIIA Non-Small Cell Lung Cancer
United States
Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)Completed
NCT01279850N/AUpdated Oct 10, 2023
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Neuropathic Pain
Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)Completed
NCT01773993N/AUpdated Oct 10, 2023
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Pain Associated With Fibromyalgia

Previous page Next page